Medpace Holdings Inkomsten in het verleden
Verleden criteriumcontroles 6/6
Medpace Holdings is de winst gegroeid met een gemiddeld jaarlijks percentage van 25%, terwijl de Life Sciences industrie de winst jaarlijks groeide met 12.7%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 20.4% per jaar. Het rendement op eigen vermogen van Medpace Holdings is 41.5%, en het heeft een nettomarge van 17.7%.
Belangrijke informatie
25.0%
Groei van de winst
28.8%
Groei van de winst per aandeel
| Life Sciences Groei van de industrie | 21.5% |
| Inkomstengroei | 20.4% |
| Rendement op eigen vermogen | 41.5% |
| Nettomarge | 17.7% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Medpace: Buy The Short-Term Pain For Long-Term Gains
Oct 26Why Medpace Holdings Is A 'Better Mousetrap'
Oct 16Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors
Sep 19
Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Sep 02Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity
Aug 20Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem
Jul 31Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 25What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E
Jun 18Medpace: Clear Winner If China Blockade Succeeds
Jun 04A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
May 22Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Apr 12Medpace: Exceptional Performance, Almost Fully Priced In
Mar 11Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors
Feb 18Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Feb 09A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jan 25Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Jan 10Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price
Dec 26Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?
Nov 08Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate
Oct 23If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity
Oct 10Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Aug 27Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Jul 31A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jul 18Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Jul 04Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?
May 25Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Apr 27An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
Apr 12We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
Mar 27Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Feb 14What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?
Jan 16Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 03Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Dec 20Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet
Nov 16Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%
Nov 03Opbrengsten en kosten
Hoe Medpace Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 2,071 | 366 | 177 | 0 |
| 30 Jun 24 | 2,030 | 340 | 169 | 0 |
| 31 Mar 24 | 1,963 | 312 | 167 | 0 |
| 31 Dec 23 | 1,886 | 283 | 161 | 0 |
| 30 Sep 23 | 1,782 | 273 | 152 | 0 |
| 30 Jun 23 | 1,673 | 268 | 146 | 0 |
| 31 Mar 23 | 1,563 | 257 | 140 | 0 |
| 31 Dec 22 | 1,460 | 245 | 131 | 0 |
| 30 Sep 22 | 1,374 | 227 | 126 | 0 |
| 30 Jun 22 | 1,286 | 209 | 118 | 0 |
| 31 Mar 22 | 1,213 | 199 | 112 | 0 |
| 31 Dec 21 | 1,142 | 181 | 108 | 0 |
| 30 Sep 21 | 1,094 | 182 | 103 | 0 |
| 30 Jun 21 | 1,028 | 175 | 98 | 0 |
| 31 Mar 21 | 955 | 159 | 93 | 0 |
| 31 Dec 20 | 926 | 145 | 92 | 0 |
| 30 Sep 20 | 896 | 124 | 91 | 0 |
| 30 Jun 20 | 882 | 107 | 97 | 0 |
| 31 Mar 20 | 891 | 110 | 99 | 0 |
| 31 Dec 19 | 861 | 100 | 95 | 0 |
| 30 Sep 19 | 823 | 93 | 95 | 0 |
| 30 Jun 19 | 786 | 88 | 84 | 0 |
| 31 Mar 19 | 742 | 78 | 81 | 0 |
| 31 Dec 18 | 705 | 73 | 76 | 0 |
| 30 Sep 18 | 612 | 61 | 72 | 0 |
| 30 Jun 18 | 531 | 52 | 70 | 0 |
| 31 Mar 18 | 456 | 45 | 64 | 0 |
| 31 Dec 17 | 386 | 39 | 63 | 0 |
| 30 Sep 17 | 382 | 28 | 63 | 0 |
| 30 Jun 17 | 379 | 23 | 63 | 0 |
| 31 Mar 17 | 377 | 18 | 63 | 0 |
| 31 Dec 16 | 371 | 13 | 62 | 0 |
| 30 Sep 16 | 361 | 5 | 65 | 0 |
| 30 Jun 16 | 348 | 0 | 60 | 0 |
| 31 Mar 16 | 332 | -5 | 57 | 0 |
| 31 Dec 15 | 320 | -9 | 54 | 0 |
| 31 Dec 14 | 290 | -16 | 40 | 0 |
| 31 Dec 13 | 244 | 25 | 35 | 0 |
Kwaliteitswinsten: MEDP heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (17.7%) MEDP } zijn hoger dan vorig jaar (15.3%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van MEDP is de afgelopen 5 jaar aanzienlijk gegroeid met 25% per jaar.
Versnelling van de groei: De winstgroei van MEDP over het afgelopen jaar ( 33.9% ) overtreft het 5-jarig gemiddelde ( 25% per jaar).
Winst versus industrie: De winstgroei MEDP over het afgelopen jaar ( 33.9% ) overtrof de Life Sciences -sector -4.7%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 41.5% ) van MEDP wordt als uitstekend beschouwd.